Response (lnBR) | Depression symptoms (SMD) | |||||||
---|---|---|---|---|---|---|---|---|
constant1 | beta2 | p | R² | constant1 | beta2 | p | R² | |
% early onset | 0.34 | −0.30 | .564 | .06 | 0.43 | −0.63 | .255 | .19 |
baseline severity | −0.66 | 0.04 | .160 | .28 | −0.89 | 0.05 | .129 | .32 |
diagnosis (reference dysthymia) | −0.05 | .69 | −0.18 | .69 | ||||
% chronic MD | 1.44 | .028 | 0.88 | .252 | ||||
% recurrent without remission | −1.16 | .211 | −0.88 | .312 | ||||
% double depression | 0.40 | .085 | 0.81 | .111 | ||||
mean age | 1.46 | −0.03 | .463 | .09 | 0.75 | −0.02 | .760 | .01 |
% female | −0.55 | 1.13 | .373 | .13 | −0.77 | 1.43 | .372 | .12 |
sessions | −0.13 | 0.02 | .631 | .03 | −0.27 | 0.03 | .560 | .04 |
treatment duration (weeks) | 0.31 | −0.01 | .521 | .06 | 0.37 | −0.02 | .137 | .19 |
setting outpatient (vs. inpatient) | 0.39 | −0.24 | .348 | .15 | 0.29 | −0.20 | .469 | .07 |
type of PT (reference IPT) | 0.07 | .57 | −0.01 | .40 | ||||
CBT | 0.15 | .555 | 0.06 | .846 | ||||
CBASP | 0.33 | .002 | 0.34 | .028 | ||||
BSP | −0.23 | .365 | −0.05 | .807 | ||||
type of medication SSRI (vs. others) | 0.42 | −0.40 | ≤.001 | .72 | 0.53 | −0.54 | .003 | .64 |
low risk of bias (vs. medium) | 0.28 | −0.12 | .599 | .05 | 0.21 | −0.10 | .754 | .01 |
total N in study | 0.23 | −0.00 | .756 | .02 | 0.13 | 0.00 | .980 | .00 |
multiple regression analysis | 0.33 | 0.79 | 0.38 | .78 | ||||
% chronic MD | 0.51 | .317 | 0.54 | .237 | ||||
CBASP | −0.66 | .769 | −0.01 | .969 | ||||
type of medication SSRI (vs. others) | −0.35 | .021 | −0.46 | .035 |